Financial Snapshot

Revenue
$1.588M
TTM
Gross Margin
99.77%
TTM
Net Earnings
-$944.5K
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
18.19%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$4.911M
Q2 2024
Cash
Q2 2024
P/E
-0.4210
Nov 29, 2024 EST
Free Cash Flow
-$839.6K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue $2.552M $2.928M $2.029M $503.5K $11.56K $40.00K $60.00K $140.0K $30.00K $0.00 $0.00 $0.00 $0.00
YoY Change -12.83% 44.33% 302.88% 4254.13% -33.33% -57.14% 366.67%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue $2.552M $2.928M $2.029M $503.5K $11.56K $40.00K $60.00K $140.0K $30.00K $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $16.17K $45.95K $38.15K $22.50K $0.00 $0.00
Gross Profit $2.536M $2.882M $1.990M $481.0K $0.00 $0.00
Gross Profit Margin 99.37% 98.43% 98.12% 95.53%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Selling, General & Admin $1.924M $2.399M $1.946M $690.1K $3.404M $2.029M $1.838M $1.189M $1.947M $1.360M $10.00K $0.00
YoY Change -19.79% 23.28% 182.02% -79.73% 67.71% 10.4% 54.55% -38.92% 43.2% 13500.0%
% of Gross Profit 75.88% 83.25% 97.77% 143.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $455.9K $449.9K $450.5K $446.9K $1.152K $13.80K $14.96K $14.96K $2.217K $0.00 $0.00
YoY Change 1.33% -0.14% 0.82% 38689.41% -91.65% -7.72% 0.01% 574.61%
% of Gross Profit 17.98% 15.61% 22.64% 92.9%
Operating Expenses $1.924M $2.399M $1.946M $667.6K $3.404M $2.029M $2.478M $1.189M $1.947M $1.360M $20.00K $0.00 $0.00 $0.00
YoY Change -19.79% 23.28% 191.52% -80.39% 67.71% -18.09% 108.31% -38.92% 43.2% 6700.0%
Operating Profit $611.7K $482.7K $44.29K -$186.6K -$3.392M -$2.029M -$2.438M -$1.129M -$1.807M $0.00 $0.00
YoY Change 26.71% 989.85% -123.74% -94.5% 67.14% -16.75% 115.84% -37.51%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Interest Expense -$706.4K -$656.0K -$907.2K -$522.8K -$531.5K $2.300M $201.4K $162.8K $73.20K $30.00K
YoY Change 7.69% -27.69% 73.53% -1.64% -123.1% 1042.39% 23.66% 122.46% 143.99%
% of Operating Profit -115.49% -135.89% -2048.13%
Other Income/Expense, Net -$706.4K -$656.0K -$907.2K -$522.8K -$1.512M -$2.403M -$334.2K
YoY Change 7.69% -27.69% 73.53% -65.42% -37.1% 619.12%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Pretax Income -$94.76K -$173.2K -$862.9K -$709.3K -$4.904M -$4.433M -$2.772M -$2.211M -$1.729M -$1.300M $0.00 $0.00 $0.00 $0.00
YoY Change -45.3% -79.92% 21.65% -85.53% 10.62% 59.92% 25.38% 27.84% 33.03%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$94.76K -$173.2K -$862.9K -$709.3K -$4.904M -$4.433M -$2.772M -$2.211M -$1.729M -$1.300M $0.00 $0.00 $0.00 $0.00
YoY Change -45.31% -79.92% 21.65% -85.53% 10.62% 59.92% 25.38% 27.84% 33.03%
Net Earnings / Revenue -3.71% -5.92% -42.54% -140.88% -42404.6% -6929.74% -3684.61% -1235.25% -4333.33%
Basic Earnings Per Share $0.00 -$0.01 -$0.04
Diluted Earnings Per Share $0.00 -$7.119K -$36.15K -$30.18K -$213.3K -$220.9K -$145.8K -$129.8K -$104.0K -$81.50K $0.00 $0.00 $0.00 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Cash & Short-Term Investments $1.135M $1.341M $696.4K $183.0K $465.8K $198.1K $1.630K $20.00 $201.4K $270.0K $0.00 $0.00 $0.00 $0.00
YoY Change -15.37% 92.59% 280.51% -60.71% 135.11% 12055.83% 8050.0% -99.99% -25.43%
Cash & Equivalents $1.135M $1.341M $696.4K $183.0K $465.8K $198.1K $1.630K $20.00 $201.4K
Short-Term Investments $100.0K $0.00
Other Short-Term Assets $33.39K $72.74K $22.96K $12.65K $897.8K $3.884M $62.96K $259.1K $2.287M $2.260M $0.00
YoY Change -54.1% 216.81% 81.5% -98.59% -76.89% 6069.38% -75.7% -88.67% 1.18%
Inventory
Prepaid Expenses
Receivables $0.00 $258.9K $124.6K $11.56K
Other Receivables $294.7K $41.57K $37.16K $32.27K
Total Short-Term Assets $1.334M $1.709M $1.020M $357.4K $1.407M $4.082M $64.59K $261.7K $2.494M $2.530M $0.00 $0.00 $0.00 $0.00
YoY Change -21.92% 67.54% 185.3% -74.6% -65.52% 6220.45% -75.31% -89.51% -1.43%
Property, Plant & Equipment $13.48M $13.73M $14.00M $14.43M $7.573M $1.687M $684.2K $5.280K $6.400K $10.00K $0.00
YoY Change -1.79% -1.95% -2.94% 90.5% 348.84% 146.6% 12857.95% -17.5% -36.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $2.669M $2.727M $4.396M $3.179M $203.1K $0.00 $0.00
YoY Change -100.0% -2.13% -37.97% 38.3% 1465.12%
Total Long-Term Assets $13.82M $13.73M $14.04M $14.51M $10.36M $5.375M $5.999M $4.049M $1.501M $1.010M $0.00 $0.00 $0.00 $0.00
YoY Change 0.67% -2.25% -3.2% 40.07% 92.72% -10.4% 48.17% 169.74% 48.61%
Total Assets $15.15M $15.44M $15.06M $14.87M $11.77M $9.457M $6.064M $4.310M $3.995M $3.540M $0.00 $0.00 $0.00 $0.00
YoY Change
Accounts Payable $102.3K $82.50K $97.50K $65.00K $265.3K $268.1K $624.6K $385.4K $85.30K $30.00K $0.00 $0.00
YoY Change 23.94% -15.38% 50.0% -75.5% -1.04% -57.08% 62.08% 351.79% 184.33%
Accrued Expenses $52.89K $65.25K $64.63K $77.62K $121.9K $46.61K $86.25K $118.8K $0.00 $10.00K $0.00
YoY Change -18.94% 0.96% -16.74% -36.31% 161.49% -45.96% -27.37% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $5.082M $150.0K $150.0K $150.3K $385.0K $521.3K $1.070M $1.158M $900.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 3287.77% 0.0% -0.17% -60.97% -26.14% -51.29% -7.6% 28.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.243M $499.5K $514.3K $589.6K $781.3K $844.8K $1.801M $1.677M $997.0K $70.00K $0.00 $0.00 $0.00
YoY Change 949.62% -2.87% -12.78% -24.54% -7.52% -53.08% 7.37% 68.21% 1324.3%
Long-Term Debt $0.00 $4.919M $4.812M $4.160M $4.874M $1.782M $1.979M $2.024M $1.683M $830.0K $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 2.23% 15.67% -14.65% 173.47% -9.92% -2.25% 20.29% 102.75%
Other Long-Term Liabilities $4.204M $4.217M $4.228M $4.243M
YoY Change -0.29% -0.27% -0.36%
Total Long-Term Liabilities $4.204M $9.136M $9.040M $8.403M $4.874M $1.782M $1.979M $2.024M $1.683M $830.0K $0.00 $0.00 $0.00 $0.00
YoY Change -53.98% 1.06% 7.58% 72.41% 173.47% -9.92% -2.25% 20.29% 102.75%
Total Liabilities $9.448M $9.635M $9.554M $8.993M $5.655M $2.627M $3.779M $3.701M $2.680M $900.0K $0.00 $0.00 $0.00
YoY Change -1.95% 0.85% 6.24% 59.02% 115.26% -30.49% 2.1% 38.12% 197.76%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Basic Shares Outstanding 24.39M 24.33M 23.87M 23.50M 22.98M 20.07M 19.01M 17.03M 16.62M
Diluted Shares Outstanding 24.39M 24.33M 23.87M 23.50M 22.98M 20.07M 19.01M 17.03M 16.62M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $397.59 Thousand

About AmeriCann, Inc.

Americann, Inc. engages in the development and leasing of cannabis cultivation, processing and product manufacturing facilities. The company is headquartered in Denver, Colorado and currently employs 3 full-time employees. The company went IPO on 2013-09-10. The company has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. The company designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.

Industry: Services-Management Consulting Services Peers: CLS Holdings USA, Inc. Enveric Biosciences, Inc. Can B Corp CNS Pharmaceuticals, Inc. KIORA PHARMACEUTICALS INC GREEN HYGIENICS HOLDINGS INC. JOHNSON & JOHNSON RANGE IMPACT, INC. PALISADE BIO, INC.